Franchise opportunities compared
Amerisourcebergen Drug vs MATCO
Reviewed figures from each brand's Franchise Disclosure Document (FDD), side by side. Each figure carries its FDD year and page. This is not a ranking or recommendation, and the two FDDs may cover different years and location groups.
Initial investment · Item 7
Amerisourcebergen Drug
$5,000 – $12,000
2026 FDD · Item 7 · PDF p. 29MATCO
$104,374 – $376,241
2026 FDD · Item 7 · PDF p. 1Initial franchise fee · Item 5
Amerisourcebergen Drug
Not available
MATCO
$10,000
2026 FDD · Item 5 · PDF p. 26Royalty · Item 6
Amerisourcebergen Drug
$599
2026 FDD · Item 6 · PDF p. 23MATCO
Not available
Before you compare
- Both sets of figures come from 2026 FDDs.
- Only MATCO has reviewed Item 19 figures here.
Financial commitment
Amerisourcebergen DrugAmerisourcebergen Drug
MATCO
Amerisourcebergen Drug
MATCO
Amerisourcebergen Drug
MATCO
Amerisourcebergen Drug
MATCO
System scale & health
Amerisourcebergen DrugAmerisourcebergen Drug
MATCO
Amerisourcebergen Drug
MATCO
Amerisourcebergen Drug
MATCO
Amerisourcebergen Drug
MATCO
Amerisourcebergen Drug
MATCO
Financial performance (Item 19), by location group
Amerisourcebergen DrugNo reviewed Item 19 figures
Item 19 groups are shown separately and never combined. Revenue or sales figures are not profit. Net outlet change and turnover are Franopolis calculations from the disclosed counts; turnover is a count-based rate, not a measure of owner earnings.
Amerisourcebergen Drug vs MATCO: common questions
- Which costs less to open, Amerisourcebergen Drug or MATCO?
- Amerisourcebergen Drug: $5,000 – $12,000 (2026 FDD · Item 7 · PDF p. 29); MATCO: $104,374 – $376,241 (2026 FDD · Item 7 · PDF p. 1). These are each franchisor's Item 7 estimated initial investment. The low end of the disclosed estimate is lower for Amerisourcebergen Drug. Estimates are not quotes, and the FDD years may differ.
- Which has more locations, Amerisourcebergen Drug or MATCO?
- Amerisourcebergen Drug: 2,204 (2026 FDD · Item 20 · PDF p. 55); MATCO: 1,741 (2025 FDD · Item 20 · PDF p. 85). Total outlets from Item 20. Outlet counts do not indicate territory availability or franchisee results.
- Do Amerisourcebergen Drug and MATCO disclose financial performance (Item 19)?
- Amerisourcebergen Drug has no reviewed Item 19 figures on file; MATCO has reviewed Item 19 figures for 4 location groups. Different location groups are not directly comparable, and revenue is not profit.
Answers restate the reviewed figures above. Not a ranking or recommendation.
Keep researching

Full Amerisourcebergen Drug report
Every reviewed fee, Item 19 group, outlet table and territory disclosure
Full MATCO report
Every reviewed fee, Item 19 group, outlet table and territory disclosure
